Suspended PHASE3 INTERVENTIONAL 2-arm NCT00470795

Acupuncture for Diabetic Gastroparesis

A Randomized, Placebo/Sham-Controlled, Double-Blind Crossover Study to Assess the Efficacy of Acupuncture in the Treatment of Diabetic Gastroparesis.

Sponsor: Shaare Zedek Medical Center

Conditions Diabetic Gastroparesis

Interventions Acupuncture placebo/sham acupuncture

Updated 5 times since 2017 Last updated: Dec 14, 2008 Started: Jun 30, 2009 Primary completion: Jun 30, 2010 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Protocol to be re-designed (primary outome still GCSI)

Listed as NCT00470795, this PHASE3 trial focuses on Diabetic Gastroparesis and remains suspended. Sponsored by Shaare Zedek Medical Center, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Suspended PHASE3
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE3
Jan 2021 — Jul 2024 [monthly]

Suspended PHASE3
Jun 2018 — Jan 2021 [monthly]

Suspended PHASE3
Jan 2017 — Jun 2018 [monthly]

Suspended PHASE3

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shaare Zedek Medical Center

Data source: Shaare Zedek Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel